Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167.3 USD | -0.30% | +1.60% | +7.95% |
10:48pm | Cigna to offer Humira rivals with $0 copay at specialty pharmacy | RE |
05:07pm | AbbVie Says Rinvoq Shows Superiority Versus Dupixent in Atopic Dermatitis Trial Primary Endpoint | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.95% | 297B | |
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B | |
+2.07% | 117B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie : Working With Caraway Therapeutics to Develop Small Molecule Therapeutics For Parkinson's Disease